These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 10022640

  • 1. Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease.
    Korelitz BI, Fuller SR, Warman JI, Goldberg MD.
    Am J Gastroenterol; 1999 Feb; 94(2):424-6. PubMed ID: 10022640
    [Abstract] [Full Text] [Related]

  • 2. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
    Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
    [Abstract] [Full Text] [Related]

  • 3. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 4. Management of varicella infection during the course of inflammatory bowel disease.
    Mouzas IA, Greenstein AJ, Giannadaki E, Balasubramanian S, Manousos ON, Sachar DB.
    Am J Gastroenterol; 1997 Sep; 92(9):1534-7. PubMed ID: 9317080
    [Abstract] [Full Text] [Related]

  • 5. [Severe varicella zoster pneumonia during the course of treatment with azathioprine for Crohn's disease].
    Lemyze M, Tavernier JY, Chevalon B, Lamblin C.
    Rev Mal Respir; 2003 Nov; 20(5 Pt 1):773-6. PubMed ID: 14631259
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T, Iwao Y, Yajima T, Inoue N, Ueno Y, Takaishi H, Watanabe M, Ishii H.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
    [Abstract] [Full Text] [Related]

  • 7. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease.
    Ananthakrishnan AN, Attila T, Otterson MF, Lipchik RJ, Massey BT, Komorowski RA, Binion DG.
    J Clin Gastroenterol; 2007 Aug; 41(7):682-8. PubMed ID: 17667053
    [Abstract] [Full Text] [Related]

  • 8. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA.
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [Abstract] [Full Text] [Related]

  • 9. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW, Maan AK, Hansoti B, Satsangi J, Arnott ID.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):220-7. PubMed ID: 17988235
    [Abstract] [Full Text] [Related]

  • 10. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 01; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 12. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM.
    Hepatogastroenterology; 2006 Jun 01; 53(69):399-404. PubMed ID: 16795981
    [Abstract] [Full Text] [Related]

  • 13. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome.
    Baiocco PJ, Korelitz BI.
    J Clin Gastroenterol; 1984 Jun 01; 6(3):211-6. PubMed ID: 6144706
    [Abstract] [Full Text] [Related]

  • 14. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D, Jovanović J, Hrnjaković-Cvjetković I, Brkić S, Bogdanović M.
    Med Pregl; 1999 Jun 01; 52(3-5):125-8. PubMed ID: 10518396
    [Abstract] [Full Text] [Related]

  • 15. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study.
    Lau A, Chande N, Ponich T, Gregor JC.
    Aliment Pharmacol Ther; 2008 Sep 01; 28(5):606-13. PubMed ID: 18564323
    [Abstract] [Full Text] [Related]

  • 16. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
    Andoh A, Tsujikawa T, Ban H, Hashimoto T, Bamba S, Ogawa A, Sasaki M, Saito Y, Fujiyama Y.
    J Gastroenterol Hepatol; 2008 Sep 01; 23(9):1373-7. PubMed ID: 18662197
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May 01; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

  • 18. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM.
    J Pediatr; 2000 Dec 01; 137(6):794-9. PubMed ID: 11113835
    [Abstract] [Full Text] [Related]

  • 19. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
    Christodoulou D, Katsanos K, Baltayannis G, Tzabouras N, Tsianos EV.
    Hepatogastroenterology; 2003 Dec 01; 50(52):1021-4. PubMed ID: 12845970
    [Abstract] [Full Text] [Related]

  • 20. Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease.
    Disanti W, Rajapakse RO, Korelitz BI, Panagopoulos G, Bratcher J.
    Clin Gastroenterol Hepatol; 2006 Aug 01; 4(8):1025-9. PubMed ID: 16765651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.